NO148838B - PROCEDURE FOR THE PREPARATION OF A NON-ADHESIVE, MULTIPLE, PHARMACOLOGICAL PROPERTY BALLIC ACID COMPLEXING ADSORABLE PREPARATION - Google Patents
PROCEDURE FOR THE PREPARATION OF A NON-ADHESIVE, MULTIPLE, PHARMACOLOGICAL PROPERTY BALLIC ACID COMPLEXING ADSORABLE PREPARATION Download PDFInfo
- Publication number
- NO148838B NO148838B NO780367A NO780367A NO148838B NO 148838 B NO148838 B NO 148838B NO 780367 A NO780367 A NO 780367A NO 780367 A NO780367 A NO 780367A NO 148838 B NO148838 B NO 148838B
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- poly
- methyl
- imino
- weight
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 32
- 238000000034 method Methods 0.000 title claims description 15
- 239000002253 acid Substances 0.000 title description 2
- 239000000853 adhesive Substances 0.000 title description 2
- 230000000536 complexating effect Effects 0.000 title 1
- 230000000144 pharmacologic effect Effects 0.000 title 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 37
- 239000002156 adsorbate Substances 0.000 claims description 24
- 229910052814 silicon oxide Inorganic materials 0.000 claims description 16
- 239000000725 suspension Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 6
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 210000000941 bile Anatomy 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 description 15
- 239000000377 silicon dioxide Substances 0.000 description 7
- 239000002775 capsule Substances 0.000 description 5
- 238000007580 dry-mixing Methods 0.000 description 5
- 229910021485 fumed silica Inorganic materials 0.000 description 5
- 235000012239 silicon dioxide Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 4
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 3
- 239000003613 bile acid Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229920001800 Shellac Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 125000001841 imino group Chemical group [H]N=* 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000004208 shellac Substances 0.000 description 2
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 2
- 229940113147 shellac Drugs 0.000 description 2
- 235000013874 shellac Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- VXEGSRKPIUDPQT-UHFFFAOYSA-N 4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline Chemical compound C1=CC(OC)=CC=C1N1CCN(C=2C=CC(N)=CC=2)CC1 VXEGSRKPIUDPQT-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 230000003312 cholesterol blood level Effects 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013766 direct food additive Nutrition 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 239000002702 enteric coating Substances 0.000 description 1
- 238000009505 enteric coating Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- -1 flavorings Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002900 methylcellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 125000005498 phthalate group Chemical class 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000005049 silicon tetrachloride Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Description
Foreliggende oppfinnelse angår en fremgangsmåte ved fremstilling av et ikke-klebende, frittrislende, farmakologisk godtagbart gallesyrekompleksdannende adsorbat-preparat ved forening av poly-[{methyl-(3-trimethylammoniumpropyl)-iminoj-trimethylen-kloridj og brent siliciumoxyd og tørking av det erholdte produkt. The present invention relates to a method for the production of a non-sticky, free-flowing, pharmacologically acceptable bile acid complex-forming adsorbate preparation by combining poly-[{methyl-(3-trimethylammoniumpropyl)-iminoj-trimethylene chloridej and burnt silicon oxide and drying the product obtained .
Poly-[{methyl-(3-trimethyl.arrmoniumpropyl) -imino J-trimethylendiklorid er meget virksom: som gallesyrekompleksdanner . Poly-[[methyl-(3-trimethyl-amttoniumpropyl) -imin oj-trimethylendiklorid , er imidlertid ekstremt hygroskopisk, og når det utsettes for luft selv ved relativt lave fuktighetsgrader, henflyter det hurtig under dannelse av et klebrig, ubearbeidbart produkt, og til slutt en oppløsning av polymeren. Poly-[{methyl-(3-trimethyl.ammoniumpropyl)-imino J-trimethylene dichloride is very effective: as a bile acid complex former. Poly-[[methyl-(3-trimethyl-amttoniumpropyl)-imine oj-trimethylene dichloride, however, is extremely hygroscopic, and when exposed to air even at relatively low humidity levels, it rapidly flows to form a sticky, unworkable product, and to finally a solution of the polymer.
Denne hygroskopiske egenskap har vært et stort problem ved fremstilling av preparater av poly-[^methyl-(3-trimethylammoniumpropy]> imino j-trimethylendiklorid] , og selv når opparbeidelsen, f.eks. This hygroscopic property has been a major problem in the production of preparations of poly-[^methyl-(3-trimethylammonium propy]> imino j-trimethylene dichloride] , and even when the preparation, e.g.
ved innkapsling eller tablettering, utføres under vannfrie betingelser, absorberer de fremstilte tabletter og kapsler hurtig vann under vanlige atmosfæriske betingelser'(idet beleggene ved slike kapsler er permeable for vann) og danner utilfredsstillende klebrige, kakende produkter. in the case of encapsulation or tableting, carried out under anhydrous conditions, the manufactured tablets and capsules rapidly absorb water under normal atmospheric conditions' (since the coatings of such capsules are permeable to water) and form unsatisfactory sticky, caking products.
Preparater omfattende i det vesentlige ensartede pulverformige blandinger av poly- [|_methyl-(3-trimethyl:ammoniumpropyl)-imino J-trimethylendiklorid] med forskjellige farmakologisk godtagbare faste bærere, som pulverisert siliciumoxyd, stivelse, Preparations comprising substantially uniform powdery mixtures of poly-[|_methyl-(3-trimethyl:ammoniumpropyl)-imino J-trimethylene dichloride] with various pharmacologically acceptable solid carriers, such as powdered silicon oxide, starch,
talkum, cellulose og kaolin, er, når de fremstilles ved omhyggelig tørrblanding av bestanddelene (som i en kulemølle) under i det vesentlige vannfrie betingelser, klebrige av karakter, og blir vanligvis klebrige og kakende efter relativt kort utsettelse for luft ved 25% relativ fuktighet. talc, cellulose and kaolin, when prepared by careful dry mixing of the ingredients (as in a ball mill) under essentially anhydrous conditions, are sticky in nature, and usually become sticky and caking after a relatively short exposure to air at 25% relative humidity .
Det har nu vist seg at i det vesentlige ikke-klebende, pulverisert poly-[^methyl-(3-trimethy]ammoniumpropyl)-imino j-trimethylendiklorid]-adsorbatpreparater, som forblir frittrislende og ikke-kakende, selv efter lengre kontakt med fuktig luft av 76% relativ fuktighet, kan fremstilles. It has now been found that substantially non-sticky, powdered poly-[^methyl-(3-trimethy]ammoniumpropyl)-imino j-trimethylene dichloride] adsorbate preparations, which remain free-flowing and non-caking, even after prolonged contact with moist air of 76% relative humidity, can be produced.
Fremgangsmåten ifølge oppfinnelsen er således kjennetegnet The method according to the invention is thus characterized
ved at der dannes en i det vesentlige ensartet suspensjon av brent siliciumoxyd i 10 til 50 ganger dets vekt av vann, at der til denne suspensjon under hurtig omrøring langsomt tilsettes en fortynnet vandig oppløsning av poly-£ £methyl-(3-trimethylammoniumpropyl)-iminoj-trimethylendikloridj, og at vannet fordampes fra den dannede suspensjon under nedsatt trykk under omrøring og opprettholdelse av blandingens temperatur ved 25 - 40°C. Det foretrekkes i alminnelighet å anvende omtrent like vektmengder, på tørr basis, in that an essentially uniform suspension of burnt silicon oxide is formed in 10 to 50 times its weight of water, that a dilute aqueous solution of poly-££methyl-(3-trimethylammoniumpropyl)- iminoj-trimethylene dichloridej, and that the water is evaporated from the formed suspension under reduced pressure while stirring and maintaining the temperature of the mixture at 25 - 40°C. It is generally preferred to use approximately equal amounts by weight, on a dry basis,
av brent siliciumdioxyd og poly-[^methyl-(3-trimethylammoniumpropyl)-imino J-trimethylendiklorid, skjønt i det vesentlige ikke-klebende adsorbatpreparater fremstilles under anvendelse av et vektforhold på 40 deler brent siliciumoxyd til 60 deler polymer. Brent siliciumoxyd-polymere adsorbater inneholdende inntil 75% brent siliciumoxyd er likeledes ikke-klebende, og effektive som gallesyre-kompleksdannere, men anvendes vanligvis ikke på grunn av deres økede mengde av brent siliciumoxydmateriale. of fumed silica and poly-[^methyl-(3-trimethylammoniumpropyl)-imino J-trimethylene dichloride, although substantially non-adhesive adsorbate preparations are prepared using a weight ratio of 40 parts fumed silica to 60 parts polymer. Fumed silica polymeric adsorbates containing up to 75% fumed silica are likewise non-sticky, and effective as bile acid complexing agents, but are generally not used because of their increased amount of fumed silica material.
Brent siliciumdioxyd fremstilles ved å brenne siliciumtetra-klorid i en flamme av hydrogen og oxygen for å danne hovedsakelig sfæriske partikler som, mens de fremdeles er halvsmeltet, sintrer til druser av slike partikler som kalles aggregater; disse aggregater filtres under videre avkjøling og oppsamles fysikalsk til agglome-rater. De sistnevnte kan ved dis<p>ergering i en vandig oppløsning utgres fra hverandre til aggregater. Således fremstilt brent siliciumdioxvd leveres i form av et lett, voluminøst, rent hvitt, ikke-giftig, farmakologisk godtagbart pulver, godkjent av FDA Fused silicon dioxide is produced by burning silicon tetrachloride in a flame of hydrogen and oxygen to form essentially spherical particles which, while still semi-molten, sinter into druses of such particles called aggregates; these aggregates are filtered during further cooling and physically collected into agglomerates. The latter can be separated into aggregates by dispersion in an aqueous solution. The calcined silicon dioxide thus produced is supplied in the form of a light, voluminous, pure white, non-toxic, pharmacologically acceptable powder, approved by the FDA
for anvendelse som en direkte næringsmiddeltilsetning, under handelsnavnet Cab-O-S i l''0 . Et liqnende ikke-giftig, FDA-godkjent mikron-isert syntetisk siliciumoxyd loveres under handelsnavnet Syloid<®.>for use as a direct food additive, under the trade name Cab-O-S i l''0 . A similar non-toxic, FDA-approved micronized synthetic silicon oxide is promised under the trade name Syloid<®.>
Fremgangsmåten ved fremstillincr av adsorbatpreparatene ifølge oppfinnelsen utføres ved først å fremstille en i det vesentlige ensartet suspensjon av brent siliciumoxyd i 10 til 50 ganger dets vekt av vann, og langsomt tilsette til denne suspensjon, under hurtig omrøring, en fortynnet (fortrinnsvis 5%) vandig oppløsning av poly- [{methyl-( 3-trimethyl ammoniumpropyl)-imino J-trimethylendiklorid]. Tilsetningshastigheten avpasses vanligvis slik at den er avsluttet i løpet av 5 til 15 minutter, og den dannede melkeaktige suspensjon omrøres kraftig i en kort tid, f.eks. 5 til 15 minutter. Suspensjonen inndampes så til tørrhet under nedsatt trykk, under omrøring og opprettholdelse av temperaturen i området fra 25°C til 40°C. Temperaturen bør ikke overstige 50°C under inndampningstrinnene, da noe misfarv-ning av polymeren kan inntre over denne temperatur. Det gjenværende pulverformige siliciumoxyd-polymeradsorbatpreparat tørres så i vakuum ved en temperatur på fra 2 5° til 4 0°C. The process for producing the adsorbate preparations according to the invention is carried out by first preparing an essentially uniform suspension of burnt silicon oxide in 10 to 50 times its weight of water, and slowly adding to this suspension, with rapid stirring, a dilute (preferably 5%) aqueous solution of poly- [{methyl-(3-trimethyl ammonium propyl)-imino J-trimethylene dichloride]. The rate of addition is usually adjusted so that it is completed within 5 to 15 minutes, and the resulting milky suspension is vigorously stirred for a short time, e.g. 5 to 15 minutes. The suspension is then evaporated to dryness under reduced pressure, while stirring and maintaining the temperature in the range from 25°C to 40°C. The temperature should not exceed 50°C during the evaporation steps, as some discoloration of the polymer may occur above this temperature. The remaining powdered silicon oxide polymer adsorbate preparation is then dried in vacuum at a temperature of from 25° to 40°C.
Det er et foretrukket trekk ved foreliggende oppfinnelse It is a preferred feature of the present invention
at det ikke er nødvendig å anvende isolert fast polymer ved fremstilling av den fortynnede vandige oppløsning av poly-[^methyl-( 3-trimethylammoniumpropyl) -imino j-trimethylendiklorid] anvendt ved den ovennevnte fremgangsmåte for fremstilling av brent siliciumoxyd-polymer-adsorbatpreparat. Isteden kan selve den vandige polymerisasjonsreaksjonsop<p>løsning anvendes ved denne fremgangsmåte, hvorved man unngår isolering, tørring og lagring av det høyhygroskopiske poly- [{methyl-(3-trimethylammoniumpropyl)-imino J-trimethylendiklorid]. Denne foretrukne fremgangsmåte fører således til direkte fremstilling, fra den vandige polymerisa-sjonsreaksjonsoppløsning, av det ønskede poly-[{methy1-(3-tri-methy]ammoniumpropyl) -imino }-trimethylendiklorid]-brent-siliciumoxyd-adsorbatpreparat i ikke-klebrig form velegnet for farmasøyt-iske preparater. that it is not necessary to use isolated solid polymer in the preparation of the diluted aqueous solution of poly-[^methyl-(3-trimethylammoniumpropyl)-imino j-trimethylene dichloride] used in the above-mentioned method for the preparation of burnt silicon oxide polymer adsorbate preparation. Instead, the aqueous polymerization reaction solution itself can be used in this method, thereby avoiding isolation, drying and storage of the highly hygroscopic poly-[{methyl-(3-trimethylammoniumpropyl)-imino J-trimethylene dichloride]. This preferred method thus leads to the direct production, from the aqueous polymerization reaction solution, of the desired poly-[{methy1-(3-tri-methy]ammoniumpropyl)-imino}-trimethylenedichloride]burnt silicon oxide adsorbate preparation in a non-sticky form suitable for pharmaceutical preparations.
Disse poly-[{methyl-(3-trimethylammoniuiupro<p>yl) -imino J - trimethylendiklorid]-brent-siliciumoxyd-adsorbatpreparater kjennetegnes ved at polymeren, som vist ved mikroskopisk under-søkelse, danner en tynn film på overflaten av det brente siliciumoxyd, i motsetning til preparater fremstilt ved tørrblanding av bestanddelene, hvor poly- [{methyl-(3-trimethyl. ammoniumpropyl)- These poly-[{methyl-(3-trimethylammoniupro<p>yl)-imino J-trimethylene dichloride]-burnt silicon oxide adsorbate preparations are characterized in that the polymer, as shown by microscopic examination, forms a thin film on the surface of the burned silicon oxide, in contrast to preparations made by dry mixing of the components, where poly- [{methyl-(3-trimethyl. ammonium propyl)-
imino J-trimethylendiklorid]-bestanddelen, skjønt den er intimt forbundet med det brente siliciumoxyd, er tilstede i form av adskilte korn. Som kunne ventes fra disse iakttatte strukturer imino J-trimethylene dichloride] component, although intimately associated with the burnt silica, is present in the form of separate grains. As could be expected from these observed structures
og det nødvendigvis større overflateareal av polymerfiImen i de brente siliciumoxyd-polymer-adsorbatpreparater, er hygroskopisiteten av adsorbatpreparatene betraktelig større enn den for preparatet fremstilt ved tørrblanding av bestanddelene, hvor polymeren er tilstede i form av enkeltkorn. Det er virkelig forbausende at,til tross for deres større hygroskopisitet, forblir de brente siliciumoxyd-poly- [{methyl- (3-trimethyl ammoniumprcpyD-imino J-trimethylendiklorid]-adsorbat<p>reparater fullstendig ikke-klebende,, ikke-kakende og frittrislende efter flere dagers utsettelse for fuktig luft av 76% relativ fuktighet, mens preparatene erholdt ved tørr-blanding av de samme bestanddeler blir klebrige og kakende selv efter noen få timers utsettelse for fuktig luft av 35% relativ fuktighet. and the necessarily larger surface area of the polymer film in the burnt silicon oxide polymer adsorbate preparations, the hygroscopicity of the adsorbate preparations is considerably greater than that of the preparation prepared by dry mixing of the components, where the polymer is present in the form of single grains. It is truly astonishing that, despite their greater hygroscopicity, the burnt silica poly-[{methyl-(3-trimethyl ammonium prcpyD-imino J-trimethylene dichloride]-adsorbate<p>repairs remain completely non-sticky, non-caking and free-flowing after several days of exposure to moist air of 76% relative humidity, while the preparations obtained by dry-mixing the same ingredients become sticky and caking even after a few hours of exposure to moist air of 35% relative humidity.
For å illustrere de forskjeller som oppnås i produktegenskap-er ved en våt-blandeprosess kontra en tørr-blandeprosess ble to formuleringer fremstilt (1) tilnærmet like vektdeler av polymer og Cab-O-Sil ® fremstilt ved våt-blandeporsessen (prøve A) og (2) To illustrate the differences achieved in product properties by a wet-mixing process versus a dry-mixing process, two formulations were prepared (1) approximately equal parts by weight of polymer and Cab-O-Sil ® prepared by the wet-mixing process (sample A) and (2)
tilnærmet like vektdeler av polymer og Cab-O-Sil<®> fremstilt ved tørr-blandeprosessen (prøve B). approximately equal parts by weight of polymer and Cab-O-Sil<®> prepared by the dry-mix process (Sample B).
Prøvene ble utsatt for atmosfærer med forskjellige relative fuktigheter ved romtemperatur, mengden av vektøkning på grunn av fuktigheten ble målt ved forskjellige tider samtidig som flyt-egenskapene av prøvene ble observert. The samples were exposed to atmospheres of different relative humidities at room temperature, the amount of weight gain due to the humidity was measured at different times while the flow properties of the samples were observed.
Resultatene var som følger: The results were as follows:
Prøve B var kakende ved alle de angitte relative fuktigheter og tidspunkter. Sample B was caking at all the indicated relative humidities and times.
* Ubetydelig kaking av prøve A ble observert bare ved 76% relativ fuktighet etter 24 og 48 timer. Ved alle de andre tidspunkter og relative fuktigheter var denne prøve frittstrømmende. * Negligible caking of sample A was observed only at 76% relative humidity after 24 and 48 hours. At all other times and relative humidities, this sample was free-flowing.
Disse observasjoner viser at selvom prøve B er markert mindre hygroskopiske enn prøve / A er dets flyt-egenskaper betyde-lig mindre gunstige etter at den har vært utsatt for fuktighet. These observations show that although sample B is markedly less hygroscopic than sample / A, its flow properties are significantly less favorable after it has been exposed to moisture.
Effektiv senkning av kolesterol-blodspeil oppnåes ved oral administrasjon av bemerkelsesverdig små doser av poly-[{methyl-(3-trimethylammoniumpropyl) -imino }-trimethylendiklorid]-brent-siliciumoxyd-adsorbatpreparater.. Denne mulig- Effective lowering of cholesterol blood levels is achieved by oral administration of remarkably small doses of poly-[{methyl-(3-trimethylammoniumpropyl)-imino }-trimethylenedichloride]-burnt-silicon-oxide-adsorbate preparations.. This possible-
gjør en fleksibilitet ved opparbeidelse som tidligere var uopp-nåelig. Disse poly-[(,methyl-(3-trimethylammoniumpropyl) -imino - trimethylendiklorid]-brent - siliciumoxydpreparater er lette, dunete, fine pulver, og anvendes passende som sådanne, eller blandet med passende mengder av konvensjonelle farmasøytisk godtagbare bindemidler og/eller ytterligere faste bærermaterialer, som stivelse, gelatin, sukker, som glucose og lactose, methyl-cellulose, naturlig og syntetisk talkum og syntetiske gummier. Preparatene fremstilles fortrinnsvis i enhetsdoseformer som tabletter eller fylte gelatinkapsler, eller eventuelt kan den forutmålte dose innesluttes i en folie eller papirkonvolutt som lett kan rives opp og tilsettes til drikkbare væsker som frukt-safter og andre drikker. Enhetsdosen kan også innbefatte til-leggsvitaminer og mineraler. Enhetsdosepreparatet kan inneholde fra 10% til 9 9 vekt% av poly-[[methyl-(3-trimethyl ammoniumpropyl) - imino '-trimethylendiklorid]-brent-siliciumoxyd-adsorbatpreparat, idet det gjenværende er bærere, smakstoffer, eksipienter og r j r-.lingn~.idl er. i en slik enhetsdose kan den aktive polymer utgjøre fra 100 mg opp til 10 g i pulverpakker. enables a flexibility in processing that was previously unattainable. These poly-[(,methyl-(3-trimethylammoniumpropyl)-imino-trimethylenedichloride]-fused silica preparations are light, fluffy, fine powders, and are conveniently used as such, or mixed with suitable amounts of conventional pharmaceutically acceptable binders and/or additional solid carrier materials, such as starch, gelatin, sugar, such as glucose and lactose, methyl-cellulose, natural and synthetic talc and synthetic gums. The preparations are preferably produced in unit dose forms such as tablets or filled gelatin capsules, or optionally the pre-measured dose can be enclosed in a foil or paper envelope which can be easily torn up and added to potable liquids such as fruit juices and other drinks. The unit dose may also include additional vitamins and minerals. The unit dose preparation may contain from 10% to 99% by weight of poly-[[methyl-(3-trimethyl ammonium propyl) - imino '-trimethylene dichloride] burnt silicon oxide adsorbate preparation, the remainder being carriers, flavorings, excipients and r j r-.lingn~.idl is. in such a unit dose, the active polymer can amount from 100 mg up to 10 g in powder packets.
For bekvem administrasjon foretrekkes det å anvende tabletter eller kapsler inneholdende 300-600 mg av adsorbatpreparatene inneholdende like mengder av brent siliciumoxyd og poly-[{methyl-(3-trimethyl.ammoniumpropyl) -imino j-trimethylendiklorid] . Slike en-hetsdosepreparater vil således gi 150-300 mg av den gallesyre-kompleksdannende polymer, poly- [(meth<y>l- (3-trimeth<y>lamKoniumpropyl)-imino - j-trimethylendiklorid] . En kapsel eller tablett inneholdende 600 mg av adsorbatpreparatet tatt fire ganger daglig ville således gi en dagsdose på 1,2 g poly-[ [_methyl-(3-trimethylammoniumpropyl)-imino }-trimethylendiklorid] . Multiple doser, f.eks. to eller tre For convenient administration, it is preferred to use tablets or capsules containing 300-600 mg of the adsorbate preparations containing equal amounts of burnt silicon oxide and poly-[{methyl-(3-trimethyl.ammoniumpropyl)-imino j-trimethylenedichloride]. Such unit-dose preparations will thus provide 150-300 mg of the bile acid-complexing polymer, poly-[(meth<y>l-(3-trimeth<y>lamKoniumpropyl)-imino-j-trimethylenedichloride]. A capsule or tablet containing 600 mg of the adsorbate preparation taken four times a day would thus give a daily dose of 1.2 g poly-[[_methyl-(3-trimethylammoniumpropyl)-imino }-trimethylene dichloride]. Multiple doses, e.g. two or three
tabletter eller kapsler, kan selvsagt taes på en gang om ønskes. tablets or capsules, can of course be taken at once if desired.
I tilfellet av tabletter kan eventuelt en plastfilm påføres for In the case of tablets, a plastic film may optionally be applied to
å forsegle tablettene mot fuktighet, og for å maskere smaken av poly-[[methyl-(3-trimethylammoniunpropyl)-imino )-trimethylendiklorid] , på i og for seg kjent vis. Et enterisk belegg som fett, fettsyrer, voks og blandinger derav, shellack, ammoniert shellack, og syre-cellulosefthalater, kan også påføres på i og for seg kjent vis. to seal the tablets against moisture, and to mask the taste of poly-[[methyl-(3-trimethylammoniunpropyl)-imino)-trimethylene dichloride], in a manner known per se. An enteric coating such as fat, fatty acids, waxes and mixtures thereof, shellac, ammoniated shellac, and acid cellulose phthalates can also be applied in a manner known per se.
De følgende eksempler illustrerer fremgangsmåter ved ut-førelse av foreliggende oppfinnelse. The following examples illustrate methods of carrying out the present invention.
Eksempel 1 Example 1
En blanding av 40 g brent siliciumdioxyd og 1100 ml vann omrøres kraftig inntil en tynn, klumpfri, i det vesentlige ensartet suspensjon er erholdt. Denne suspensjon omrøres mens der langsamt tilsettes en oppløsning av 40 g vannfritt poly-[[methyl- (3-trimethylammoniumpropyl) -imino ' -trimethylendiklorid] A mixture of 40 g of burnt silicon dioxide and 1100 ml of water is stirred vigorously until a thin, lump-free, essentially uniform suspension is obtained. This suspension is stirred while slowly adding a solution of 40 g of anhydrous poly-[[methyl-(3-trimethylammoniumpropyl)-imino '-trimethylene dichloride]
i 300 ml vann. Den dannede suspensjon inndampes til tørrhet under nedsatt trykk, og det qjenværende adsorbat tørres i vakuum i in 300 ml of water. The resulting suspension is evaporated to dryness under reduced pressure, and the remaining adsorbate is dried in vacuum in
15 timer og males hvorved man får 85 g av et hvitt, 15 hours and milled, whereby 85 g of a white,
dunet, frittrislende, ikke-kakende pulver inneholdende 5% adsorbert fuktighet. Dette adsorbat forblir frittrislende og ikk'e-kakende ved utsettelse i tre dager for fuktig luft av 76% relativ fuktighet. fluffy, free-flowing, non-caking powder containing 5% adsorbed moisture. This adsorbate remains free-flowing and non-caking when exposed for three days to moist air of 76% relative humidity.
Eksem pel 2 Example pel 2
En blanding av 122,61 mq brent siliciumdioxyd suspenderes A mixture of 122.61 mq of burnt silicon dioxide is suspended
i 5 ml vann under anvendelse av en høyhastighetsrører. En opp-løsning inneholdende 121,1 mg vannfri vekt av poly-[(methy1-(3-trimethylammoniunpropyl)-imino }-trimethylendiklorid| i 300 ml vann tilsettes langsomt mens omrøringen fortsettes. Denne dannede melkeaktige suspensjon inndampes til tørrhet i vakuum, og det gjenværende adsorbat tørres videre i vakuum for å få et in 5 ml of water using a high speed stirrer. A solution containing 121.1 mg anhydrous weight of poly-[(methy1-(3-trimethylammoniunpropyl)-imino}-trimethylene dichloride| in 300 ml of water is added slowly while stirring is continued. This milky suspension formed is evaporated to dryness in vacuo, and the remaining adsorbate is further dried in vacuum to obtain a
brent siliciumoxyd-poly [ methyl-(3-trimethylammoniumpropyl) -imino trimethylendiklorid]-preparat i form av et dunet, hvitt, frittrislende, ikke-kakende pulverformig adsorbat, som ved utsettelse for laboratorieatmosfære (relativ fuktighet 35%) i 15 timer, fullstendig bibeholder sine frittrislende og ikke-kakende egenskaper . calcined silica-poly [methyl-(3-trimethylammoniumpropyl)-imino trimethylene dichloride] preparation in the form of a fluffy, white, free-flowing, non-caking powdery adsorbate, which, on exposure to laboratory atmosphere (35% relative humidity) for 15 hours, completely retains its free-flowing and non-caking properties.
Eksempel 3 Example 3
En blanding av 1,34 g brent siliciumdioxyd suspenderes i A mixture of 1.34 g of burnt silicon dioxide is suspended in
60 ml vann under anvendelse av en høyhastighetsrører. En opp-løsning inneholdende 1,34 g vannfri vekt av poly-[{methyl-(3-trimethyl ammoniumpropyl) -imino j-trimethylendiklorid] i 30 ml vann tilsettes langsomt under fortsatt omrøring. Den dannede melkeaktige suspensjon omrøres kraftig i ca. en halv time, og inndampes så til tørrhet i vakuum, og det gjenværende adsorbat tørres videre i vakuum hvorved man får 2,5 g av et brent siliciumoxyd-poly-[{methyl-(3-trimethyl ammoniumpropyl) -imino J-trimethylendiklorid]-preparat i form av et dunet, hvitt, frittrislende, ikke-kakende pulverformig adsorbat. Dette materiale forblir frittrislende og ikke-kakende efter lengre utsettelse for luft av 76% relativ fuktighet. 60 ml of water using a high speed mixer. A solution containing 1.34 g anhydrous weight of poly-[{methyl-(3-trimethyl ammonium propyl)-imino j-trimethylene dichloride] in 30 ml of water is added slowly with continued stirring. The formed milky suspension is stirred vigorously for approx. half an hour, and then evaporated to dryness in vacuum, and the remaining adsorbate is further dried in vacuum, whereby 2.5 g of a burnt silicon oxide-poly-[{methyl-(3-trimethyl ammonium propyl)-imino J-trimethylene dichloride] is obtained -preparation in the form of a fluffy, white, free-flowing, non-caking powdery adsorbate. This material remains free-flowing and non-caking after prolonged exposure to air of 76% relative humidity.
Poly-[{methyl-(3-trimethyl ammoniumpropyl) -imino j-trimethylendiklorid] anvendt som den gallesyre-kompleksdannede polymerbe-standdel av adsorbatpreparatene fremstilt som beskrevet i de fore-gående eksempler, kan fremstilles i henhold til forskjellige fremgangsmåter beskrevet i US patentansøkninger nr. 570 910 innlevert 23. april 1975 , a ert: har fort til U.S. patent nr, 4U±b^c9. Den har følgende formel: Poly-[{methyl-(3-trimethyl ammonium propyl)-imino j-trimethylene dichloride] used as the bile acid-complexed polymer component of the adsorbate preparations prepared as described in the preceding examples can be prepared according to various methods described in US patent applications No. 570,910 filed April 23, 1975 , a ert: has fast to U.S. patent no, 4U±b^c9. It has the following formula:
hvor n er antallet av gjentatte enheter av polymeren. where n is the number of repeating units of the polymer.
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76949177A | 1977-02-17 | 1977-02-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO780367L NO780367L (en) | 1978-08-18 |
NO148838B true NO148838B (en) | 1983-09-19 |
NO148838C NO148838C (en) | 1983-12-28 |
Family
ID=25085598
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO780367A NO148838C (en) | 1977-02-17 | 1978-02-02 | PROCEDURE FOR THE PREPARATION OF A NON-ADHESIVE, MULTIPLE, PHARMACOLOGICAL PROPERTY BALLIC ACID COMPLEXING ADSORABLE PREPARATION |
Country Status (26)
Country | Link |
---|---|
JP (1) | JPS53102958A (en) |
AT (1) | AT363173B (en) |
AU (1) | AU518127B2 (en) |
BE (1) | BE863930A (en) |
CA (1) | CA1109395A (en) |
CH (1) | CH636012A5 (en) |
DE (1) | DE2806707A1 (en) |
DK (1) | DK46578A (en) |
ES (1) | ES466892A1 (en) |
FI (1) | FI67483C (en) |
FR (1) | FR2381079A1 (en) |
GB (1) | GB1567294A (en) |
GR (1) | GR66100B (en) |
HU (1) | HU177685B (en) |
IE (1) | IE46408B1 (en) |
IL (1) | IL53978A (en) |
IT (1) | IT7848013A0 (en) |
LU (1) | LU79071A1 (en) |
NL (1) | NL7801240A (en) |
NO (1) | NO148838C (en) |
NZ (1) | NZ186399A (en) |
PH (1) | PH15263A (en) |
PL (1) | PL122299B1 (en) |
PT (1) | PT67663B (en) |
SE (1) | SE433170B (en) |
ZA (1) | ZA78913B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5624963A (en) * | 1993-06-02 | 1997-04-29 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5703188A (en) * | 1993-06-02 | 1997-12-30 | Geltex Pharmaceuticals, Inc. | Process for removing bile salts from a patient and compositions therefor |
US5900475A (en) * | 1994-06-10 | 1999-05-04 | Geltex Pharmaceuticals, Inc. | Hydrophobic sequestrant for cholesterol depletion |
US6129910A (en) * | 1993-06-02 | 2000-10-10 | Geltex Pharmaceuticals, Inc. | Water-insoluble noncrosslinked bile acid sequestrants |
US5929184A (en) * | 1993-06-02 | 1999-07-27 | Geltex Pharmaceuticals, Inc. | Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants |
US5607669A (en) * | 1994-06-10 | 1997-03-04 | Geltex Pharmaceuticals, Inc. | Amine polymer sequestrant and method of cholesterol depletion |
US5618530A (en) * | 1994-06-10 | 1997-04-08 | Geltex Pharmaceuticals, Inc. | Hydrophobic amine polymer sequestrant and method of cholesterol depletion |
TW474813B (en) * | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
US5709880A (en) * | 1995-07-10 | 1998-01-20 | Buckman Laboratories International, Inc. | Method of making tabletized ionene polymers |
EP0778027A3 (en) | 1995-12-04 | 1998-04-01 | Helmut Univ.-Prof. Dr. Wachter | Use of silica for the preparation of a medicament |
JP4010585B2 (en) * | 1996-10-15 | 2007-11-21 | 久光製薬株式会社 | Tablets containing anion exchange resin |
US6203785B1 (en) | 1996-12-30 | 2001-03-20 | Geltex Pharmaceuticals, Inc. | Poly(diallylamine)-based bile acid sequestrants |
US6423754B1 (en) | 1997-06-18 | 2002-07-23 | Geltex Pharmaceuticals, Inc. | Method for treating hypercholesterolemia with polyallylamine polymers |
US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR206115A1 (en) * | 1973-06-11 | 1976-06-30 | Merck & Co Inc | PROCEDURE TO PREPARE A NON-BRANCHED AND NON-CROSSLINK LINEAR POLYMER |
US4027009A (en) * | 1973-06-11 | 1977-05-31 | Merck & Co., Inc. | Compositions and methods for depressing blood serum cholesterol |
-
1978
- 1978-01-30 FI FI780296A patent/FI67483C/en not_active IP Right Cessation
- 1978-02-01 DK DK46578A patent/DK46578A/en not_active Application Discontinuation
- 1978-02-02 NL NL7801240A patent/NL7801240A/en not_active Application Discontinuation
- 1978-02-02 SE SE7801242A patent/SE433170B/en unknown
- 1978-02-02 NO NO780367A patent/NO148838C/en unknown
- 1978-02-06 PH PH20753A patent/PH15263A/en unknown
- 1978-02-06 GR GR55356A patent/GR66100B/el unknown
- 1978-02-06 IL IL53978A patent/IL53978A/en unknown
- 1978-02-07 NZ NZ186399A patent/NZ186399A/en unknown
- 1978-02-08 AT AT0087978A patent/AT363173B/en not_active IP Right Cessation
- 1978-02-08 AU AU33099/78A patent/AU518127B2/en not_active Expired
- 1978-02-08 CA CA296,622A patent/CA1109395A/en not_active Expired
- 1978-02-09 HU HU78ME2145A patent/HU177685B/en unknown
- 1978-02-10 IT IT7848013A patent/IT7848013A0/en unknown
- 1978-02-10 ES ES466892A patent/ES466892A1/en not_active Expired
- 1978-02-14 BE BE185141A patent/BE863930A/en not_active IP Right Cessation
- 1978-02-14 CH CH162578A patent/CH636012A5/en not_active IP Right Cessation
- 1978-02-15 GB GB6014/78A patent/GB1567294A/en not_active Expired
- 1978-02-15 LU LU79071A patent/LU79071A1/en unknown
- 1978-02-15 FR FR7804268A patent/FR2381079A1/en active Granted
- 1978-02-15 PL PL1978204642A patent/PL122299B1/en unknown
- 1978-02-16 IE IE332/78A patent/IE46408B1/en unknown
- 1978-02-16 ZA ZA00780913A patent/ZA78913B/en unknown
- 1978-02-16 DE DE19782806707 patent/DE2806707A1/en not_active Withdrawn
- 1978-02-16 PT PT67663A patent/PT67663B/en unknown
- 1978-02-17 JP JP1666278A patent/JPS53102958A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO148838B (en) | PROCEDURE FOR THE PREPARATION OF A NON-ADHESIVE, MULTIPLE, PHARMACOLOGICAL PROPERTY BALLIC ACID COMPLEXING ADSORABLE PREPARATION | |
US3873694A (en) | Direct compression tabletting composition and pharmaceutical tablets produced therefrom | |
US4824664A (en) | Effervescent couples, histamine H2 -antagonist effervescent compositions containing them and their preparation | |
US7662799B2 (en) | Powder of amino acids and method for producing the same | |
US4013775A (en) | Process for preparing a sugar tablet | |
JP2000191684A (en) | Production of dispersable sterol and stanol composition | |
TW574300B (en) | Pullulan-containing powder, manufacturing process thereof, and use thereof | |
KR950013752B1 (en) | Spray dried acetaminophen | |
US4258179A (en) | Coating agents for solid medicaments | |
CN115837012A (en) | Amlodipine dry suspension and preparation method thereof | |
CN107812195A (en) | The stabilizing pharmaceutical composition of (6S) 5 methyl tetrahydrofolate calcium salt | |
RU2313348C2 (en) | Method for preparing s-adenosylmethionine containing tablet | |
US4185088A (en) | Non-adhesive ionene quaternary polymer compositions useful as bile acid sequestrants | |
US4012498A (en) | Sustained release tablet formulations | |
US3954979A (en) | Process for preparing stabilized yeast and compositions and tableting composition and method | |
US6797835B2 (en) | Phospholipid composition and use of same | |
WO2002003967A1 (en) | Film-coating composition based on cellulose derivatives and sugar alcohols | |
JP2689458B2 (en) | Granular or powdered Vitamin B composition containing lower 1 and lower 2 | |
US5403594A (en) | Oral spiramycin formulations and method for preparing same | |
JPS63222112A (en) | Sustained release granule | |
US3398226A (en) | Complex of thiamine and a styrenemaleic anhydride copolymer | |
CN116831997B (en) | Solid pharmaceutical composition in form of tablet and preparation method thereof | |
KR101784462B1 (en) | Sweetening composition with regular ratio of components and preparation method thereof | |
GB2037773A (en) | Process for preparing stabilised vitamin D and compositions thereof | |
JPH01197432A (en) | Solution for forming sugar layers, sugar layer and formation thereof |